Form 13F-NT - Quarterly report filed by institutional managers, Notice:
SEC Accession No. 0001606074-15-000005
Filing Date
2015-11-06
Accepted
2015-11-05 19:20:04
Documents
1
Period of Report
2015-09-30
Effectiveness Date
2015-11-06

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 13F-NT  
1 primary_doc.xml 13F-NT 2307
  Complete submission text file 0001606074-15-000005.txt   3166
Mailing Address C/O IMMUNE DESIGN CORP. 1616 EASTLAKE AVE. E, SUITE 310 SEATTLE WA 98102
Business Address
Svennilson Peter (Filer) CIK: 0001606074 (see all company filings)

Type: 13F-NT | Act: 34 | File No.: 028-16412 | Film No.: 151202150